安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- 340B Drug Pricing Program | HRSA
The 340B Program enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services Manufacturers participating in Medicaid agree to provide outpatient drugs to covered entities at significantly reduced prices
- 340B Drug Pricing Program - Wikipedia
The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices
- Updates to 340B and What Pharmacists Need to Know
The 340B Drug Pricing Program is a federally mandated drug pricing program created by Congress in 1992 that allows certain health care organizations (called covered entities) to purchase specific outpatient drugs at significantly discounted prices
- Fact Sheet: The 340B Drug Pricing Program - AHA
Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for many uninsured and low-income patients
- Home - 340B Health
340B Health is a nonprofit membership organization of more than 1,600 public and private non-profit hospitals and health systems throughout the U S that participate in the 340B drug pricing program
- What Is the 340B Drug Pricing Program and Who Qualifies?
The 340B Drug Pricing Program is a federal program that requires pharmaceutical manufacturers to sell outpatient drugs at significantly reduced prices to hospitals and clinics that serve low-income and uninsured patients
- FAQ: 340B Frequently Asked Questions - ASHP
Using the 340B Drug Pricing Program is crucial to assist with hospital systems that normally would operate at a loss due to underpayment from Medicare and Medicaid
- 340B University Education Library
The 340B Prime Vendor supports the distribution of covered outpatient drugs through the 340B Drug Pricing Program and serves all 340B stakeholders
|
|
|